Anti‐thymocyte globulin‐mediated immunosenescent alterations of T cells in kidney transplant patients

OBJECTIVES: Kidney transplant (KT) is the most effective treatment for end‐stage renal disease. The immunosuppressant anti‐thymocyte globulin (ATG) has been applied for induction therapy to reduce the risk of acute transplant rejection for patients at high immunological risk. Despite its putative ro...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ga Hye, Lee, Jee Youn, Jang, Jiyeon, Kang, Yeon Jun, Choi, Seung Ah, Kim, Hyeon Chang, Park, Sungha, Kim, Myoung Soo, Lee, Won‐Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686013/
https://www.ncbi.nlm.nih.gov/pubmed/36439636
http://dx.doi.org/10.1002/cti2.1431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686013/
https://www.ncbi.nlm.nih.gov/pubmed/36439636
http://dx.doi.org/10.1002/cti2.1431

Ejemplares similares